Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert H. Hyland, DPhil
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fundacion de Investigacion de Diego
Santurce, Puerto Rico, Puerto Rico
- Alabama Liver and Digestive Specialists
Montgomery, Alabama, United States
- Advanced Clinical Research Institute
Anaheim, California, United States
- Scti Research Foundation
Coronado, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Dr. Jay Lalezari
San Francisco, California, United States
- Dr. Natalie Bzowej
San Francisco, California, United States
- Dr. David Nelson
Gainesville, Florida, United States
- Orlando Immunology Center
Orlando, Florida, United States
- Gastrointestinal Specialists of Georgia
Marietta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- Dr. Mark Sulkowski
Lutherville, Maryland, United States
- Liver Research Center Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Kansas City Gastroenterology and Hepatology
Kansas City, Missouri, United States
- Dr. Bruce Bacon
St Louis, Missouri, United States
- North Shore University Hospital
Manhasset, New York, United States
- Dr. Ira Jacobson
New York, New York, United States
- Mount Sinai School of Medicine
New York, New York, United States
- Dr. Jama Darling
Chapel Hill, North Carolina, United States
- Dr. Raj Reddy
Philadelphia, Pennsylvania, United States
- Columbia Gastroenterology and Liver Associates
Columbia, South Carolina, United States
- Dr. Eric Lawitz
San Antonio, Texas, United States
- Digestive Disease Institute Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2010
- Primary completion
- 30 Apr 2011
- Completion
- 31 May 2012
- Last update posted
- 21 Apr 2014
- Registered enrollment
- 147
- Registry id
- NCT01188772
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.